Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · RF Acquisition Corp II (RFAI)

RF Acquisition Corp II shareholders approve Nanyang Biologics merger

Mixed Impact 4 of 5 m&a Written later

RF Acquisition Corp II shareholders voted on August 19, 2026, at an extraordinary general meeting and approved the Business Combination Proposal, which covers the merger with NYB Holdings Limited and the amalgamation with Nanyang Biologics Pte. Ltd. Holders also submitted preliminary requests to redeem 3,956,323 shares for cash from the trust account, and the company says the closing may not occur and the final redemption figures cannot be determined until closing.

Key points

  • Business Combination Proposal: 6,765,584 votes for, 440,604 against, 0 abstentions, out of 7,206,188 shares present (86.36% of 8,343,765 shares entitled to vote)
  • Preliminary redemption requests for 3,956,323 RFAC ordinary shares, subject to withdrawal or reversal before closing
  • Closing remains subject to closing conditions and may not occur; final redemption amounts will be disclosed after closing
  • Other proposals, including the merger, Nasdaq issuance, incentive plan and adjournment, received the same vote counts

The filing

CompanyRF Acquisition Corp II (RFAI)
Form8-K, current report
Filed with the SECAug 20, 2026, 4:49 PM ET
Accession number0001829126-26-009168

Items reported: 5.07 Shareholder Vote Results8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.